The FDA has been methodically inspecting the largest compounding pharmacies for quality after last year's fatal meningitis outbreak was tied to a compounder. Now the agency says it has again found a link between drugs manufactured by a compounding pharmacy--this time in Cedar Park, TX--and more than two dozen patients getting bacterial bloodstream infections. The FDA says Specialty Compounding is pulling all of its sterile products dispensed since May 9. That is because 15 patients at two Texas hospitals who had received calcium gluconate injections made by Specialty Compounding contracted the infections. Specialty Compounding said the recalled products had been shipped to all 50 states, excluding North Carolina. The FDA is supporting legislation that would give it more defined powers over large compounders that ship nationally. Story | More